Literature DB >> 8278034

Balo's concentric sclerosis followed by MRI and positron emission tomography.

C O Hanemann1, A Kleinschmidt, G Reifenberger, H J Freund, R J Seitz.   

Abstract

We report a case of Balo's concentric sclerosis diagnosed in vivo by characteristic MRI changes and stereotactic biopsy. Follow-up after 6 months of immunosuppressive treatment demonstrated virtually complete clinical remission, reduction of the white matter lesions on MRI and normalisation of regional cerebral glucose metabolism as assessed by positron emission tomography not only in white matter but also in the cerebral grey matter structures with input from the affected regions.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8278034     DOI： 10.1007/bf00588396

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  9 in total

1.  MRI study of Baló's concentric sclerosis before and after immunosuppressive therapy.

Authors:  M Spiegel; H Krüger; E Hofmann; L Kappos
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

2.  On the origin of the postexcitatory inhibition seen after transcranial magnetic brain stimulation in awake human subjects.

Authors:  H Roick; H J von Giesen; R Benecke
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

3.  Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis.

Authors:  D J Brooks; K L Leenders; G Head; J Marshall; N J Legg; T Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

4.  Balo's concentric sclerosis--a case report.

Authors:  M L Chu; J Zamuco; M C Perez; A Ohnishi; Y Kuroiwa
Journal:  Folia Psychiatr Neurol Jpn       Date:  1982

5.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

6.  Positron emission tomography in a patient with progressive multifocal leukoencephalopathy.

Authors:  M Kiyosawa; T M Bosley; A Alavi; N Gupta; C H Rhodes; J Chawluk; M Kushner; P J Savino; R C Sergott; N J Schatz
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

7.  Balo's concentric demyelination diagnosed premortem.

Authors:  J Garbern; A M Spence; E C Alvord
Journal:  Neurology       Date:  1986-12       Impact factor: 9.910

8.  Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose.

Authors:  M Reivich; A Alavi; A Wolf; J Fowler; J Russell; C Arnett; R R MacGregor; C Y Shiue; H Atkins; A Anand
Journal:  J Cereb Blood Flow Metab       Date:  1985-06       Impact factor: 6.200

9.  Computed tomography, magnetic resonance imaging, positron emission tomography and evoked potentials at early stage of adrenoleukodystrophy.

Authors:  K Iinuma; K Haginoya; I Handa; A Kojima; N Fueki; J Aikawa; M Ito; J Hatazawa; T Ido
Journal:  Tohoku J Exp Med       Date:  1989-11       Impact factor: 1.848
  9 in total
  1 in total

1.  Baló's concentric sclerosis: clinical and radiologic features of five cases.

Authors:  E Karaarslan; A Altintas; U Senol; N Yeni; A Dincer; C Bayindir; N Karaagac; A Siva
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.